v3.25.1
Share Based Payments (Tables)
 12 Months Ended
Dec. 31, 2024
Share Based Payments [Abstract]  
Schedule of Share Option Plan

Tiziana Life Sciences PLC Share Option Plan

 

   2024   2023   2022 
   Weighted       Weighted       Weighted     
   Average
exercise
price
(cents)		   Options
(’000)		   Average
exercise
price
(cents)		   Options
(’000)		   Average
exercise
price
(cents)		   Options
(’000)		 
                         
Outstanding at 1 January   62    6,621    59    6,724    90    22,234 
Granted   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   (77)   (2,105)   (44)   (103)   (92)   (15,510)
Exercised   
-
    
-
    
-
    
-
    
-
    
-
 
                               
Outstanding at 31 December   69    4,516    62    6,621    59    6,724 
                               
Exercisable at 31 December   74    1,257    60    2,829    58    2,732 
   2024   2023 
   Weighted       Weighted     
   Average
exercise
price
(cents)		   Options
(’000)		   Average
exercise
price
(cents)		   Options
(’000)		 
                 
Outstanding at 1 January   73    4,268    69    2,575 
Granted   72    2,260    61    1,753 
Forfeited/Cancelled   (68)   (1,103)   (57)   (60)
Exercised   (61)   (123)   
-
    
-
 
                     
Outstanding at 31 December   69    5,302    73    4,268 
                     
Exercisable at 31 December   68    2,315    
-
    
-
 

 

   2022 
   Weighted     
   Average
exercise
price
(cents)		   Options
(’000)		 
         
Outstanding at 1 January   
-
    
-
 
Granted   69    2,575 
Forfeited/Cancelled   
-
    
-
 
Exercised   
-
    
-
 
           
Outstanding at 31 December   69    2,575 
           
Exercisable at 31 December   
-
    
-
 
Schedule of Share Options Expiry Dates and Exercise Price

Share options outstanding at the end of the year have the following expiry dates and exercise prices:

 

Grant Date  Expiry Date  Exercise
Price		   Share
Options at
31 December
2024
(’000)		 
30 April 2018  30 April 2028  $1.10           500 
6 May 2020  5 May 2028  $0.47    3,416 
23 July 2020  26 July 2030  $2.11    100 
25 August 2020  24 August 2030  $1.98    500 
Total           4,516 

Share options outstanding at the end of the year have the following expiry dates and exercise prices:

 

Grant Date  Expiry Date  Exercise
Price		   Share Options
as at 31 December
2024
(’000)		 
04 November 2022  04 November 2032  $0.67    1,850 
14 March 2023  14 March 2033  $0.57    492 
26 July 2023  26 July 2033  $0.67    700 
13 March 2024  13 March 2034  $0.50    560 
3 May 2024  3 May 2034  $0.71    1,000 
14 August 2024  14 August 2034  $1.09    200 
3 October 2024  3 October 2034  $0.82    500 
Total           5,302 

Restricted Stock Units outstanding at the end of the year have the following expiry dates and exercise prices:

 

Grant Date  Expiry Date  Exercise
Price		   Restricted
Stock at
31 December
2024
(’000)		 
08 August 2024  08 April 2034  $1.09    4,200 
Total           4,200 
Schedule of Model Inputs for Options Granted Under the Black Scholes Valuation Model

Under the Tiziana Life Sciences Ltd 2021 Equity Incentive Plan, the total expenses recognized for the year ending 31 December 2024 arising from share - based payment transactions are $962k, not including a charge of $421k for forfeitures during the year. (2023:$1,019k, 2022:$332k).

   03 October
2024		   14 August
2024		 
         
Grant date share price  $0.82   $1.09 
Exercise share price  $0.82   $1.09 
Risk free rate   3.49%   3.60%
Expected volatility   96%   95%
Option life   10 years    10 years 
Weighted average share price  $0.82   $1.09 
Weighted average fair value per share option  $0.82   $1.09 

 

   03 May
2024		   13 March
2024		 
         
Grant date share price  $0.71   $0.50 
Exercise share price  $0.71   $0.50 
Risk free rate   4.50%   4.19%
Expected volatility   99%   87%
Option life   10 years    10 years 
Weighted average share price  $0.71   $0.50 
Weighted average fair value per share option  $0.71   $0.50 

For warrants issued during the year to December 31, 2024, the Directors have estimated the fair value of the warrants using the Black-Scholes valuation model and assumptions below. No warrants were issued in 2023 or 2022.

 

   12 November
2024		 
     
Grant date share price  $0.94 
Exercise share price  $1.50 
Risk free rate   0.42%
Expected volatility   110.8%
Schedule of Restricted Stock Unit

Restricted Stock Unit

 

   2024 
   Grant     
   Date
price
(cents)		   Restricted Stock
(’000)		 
         
Outstanding at 1 January   
-
    
-
 
Granted   1.09    4,200 
Forfeited/Cancelled   
-
    
-
 
Exercised   
-
    
-
 
           
Outstanding at 31 December   1.09    4,200 
           
Exercisable at 31 December   
-
    
-
 
Schedule of Estimated the Fair Value of Warrants
   2024
$000		   2023
$000		   2022
$000		 
             
Outstanding at 1 January   
-
    697    697 
Issued   25    
-
    
-
 
Exercised   
-
    (438)   
-
 
Expired   
-
    (259)   
-
 
                
Outstanding at 31 December   25    
-
    697